Cabaletta Bio
CABA · NASDAQ
$1.61+$0.13 (+8.78%)TodayMarket closed ·
Prev close $1.48
About CABA
- Employees
- 154
- Headquarters
- PHILADELPHIA, Pennsylvania
- Listed
- Oct 25, 2019
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- cabalettabio.com
Leadership
| Name | Title | Since |
|---|---|---|
| Steven Nichtberger | — | 2017 |
| Anup Marda | — | — |
| Gwendolyn Binder-Scholl | — | — |
| Michael Gerard | — | — |
| David Chang | — | — |
| Arun Das | — | — |
| Catherine Bollard | — | — |
| Scott Brun | — | — |
| Richard Henriques | — | — |
| Mark Simon | — | 2018 |
| Shawn Tomasello | — | — |
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Oxford BioMedica OXB.L | Supplier and customer | 0.92 |
| Artisan Bio, Inc. | Supplier and customer | — |
| Children's Hospital of Philadelphia | Supplier and customer | — |
| University of Pennsylvania | Supplier and customer | — |
Similar companies
Companies in the same industry as Cabaletta Bio
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.